On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
RATIONALE: Suvorexant is a first-in-class orexin receptor antagonist for treating insomnia. There is a general concern that hypnotics may impair next-morning driving ability. OBJECTIVE: The objective of this study was to evaluate next-morning driving performance in older adults after single and repeated doses of suvorexant. METHODS: Double-blind, randomized, placebo-controlled, 4-period crossover study in 24 healthy volunteers (10 females), aged 65-80 years. Subjects were treated with suvorexant (15 and 30 mg) for eight consecutive nights, zopiclone 7.5 mg nightly on days 1 and 8, and placebo. Driving performance was assessed on days 2 and 9 (9 h after dosing) using a 1-h standardized highway driving test in normal traffic, measuring standard deviation of lateral position (SDLP). Drug-placebo differences in SDLP >2.4 cm were considered to reflect clinically meaningful driving impairment. RESULTS: Driving performance as measured by SDLP was not impaired following suvorexant. Mean drug-placebo differences in SDLP following suvorexant 15 and 30 mg on day 2 and 9 were 0.6 cm or less. Their 90 % CIs were all below the threshold of 2.4 cm for clinical relevance and included zero, indicating effects were not clinically meaningful or statistically significant. Symmetry analysis showed no significant differences between the number of participants who had SDLP differences >2.4 cm and those who had SDLP differences <-2.4 cm following suvorexant. CONCLUSIONS: There was no clinically meaningful residual effect of suvorexant 15 and 30 mg on next-morning driving (9 h after bedtime dosing) in healthy older adults, as assessed by mean changes in SDLP and by the number of participants on drug versus placebo that exceeded a predetermined threshold for clinically meaningful impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 1×
“The highest prevalence of sleeping problems is found in older people, and most users of hypnotics are elderly (Drake et al. 2003; Glass et al. 2005; Bain 2006).”
BackgroundRamaekers, J., Muntjewerff, N., & O'Hanlon, J. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04468.x · Cited by 103
Robbe, H. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)00130-4 · Cited by 91
Cited by
Herring, W. J., Roth, T., Krystal, A. D., & Michelson, D. (2019) · Journal of Sleep Research · doi:10.1111/jsr.12782 · Cited by 53
Zhou, M., Tang, J., Li, S., Li, Y., & Zhao, M. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.1029554 · Cited by 24
“…2012, 2013, 2014, 2016, 2017, 2020; Hoever et al., 2012, 2013; Uchimura et al., 2012a,b; Sun et al., 2013; Leufkens et al., 2014; Tek et al., 2014; Vermeeren et al., 2014, 2016, 2019; Spierings et al., 2015; Connor et al., 2016; Dauvilliers et al., 2020; Dopheide, 2020; Karppa et al., 2020;…”
Sleep Medicine - Asleep or Awake?
(2024) · doi:10.5772/intechopen.104201 · Cited by 5
Metadata
- Authors
- Vermeeren, A., Vets, E., Vuurman, E. F. P. M., Van Oers, A. C. M., Jongen, S., Laethem, T., Heirman, I., Bautmans, A., Palcza, J., Li, X., Troyer, M. D., Wrishko, R., McCrea, J., & Sun, H.
- Venue
- Psychopharmacology
- Published
- 2016-07-16
- Volume
- 233
- Issue
- 18
- Pages
- 3341-3351
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2467564998
- Cited by
- 52
- References
- 4
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly. https://app.cochat.ai/papers/10.1007/s00213-016-4375-x
- The paper
- Vermeeren, A., Vets, E., Vuurman, E. F. P. M., Van Oers, A. C. M., Jongen, S., Laethem, T., Heirman, I., Bautmans, A., Palcza, J., Li, X., Troyer, M. D., Wrishko, R., McCrea, J., & Sun, H. (2016). On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly. Psychopharmacology. https://doi.org/10.1007/s00213-016-4375-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.